STOCKCHASE

Not cheap compared to its US competitors but they have a very good product, which is totally transparent large corporations and insurance groups helping them to see what their drug costs are. Year-over-year sales growth is up 132%.

2011-08-26

BUY

44.870

Have a very transparent system for connecting drug payers so employers with workforces can reduce overall costs. A business of economy of scale. Not cheap but have very significant cash flow. Made enough to be able to pay for a recent acquisition out of cash. Analysts are forecasting an in crease of earnings from $1.09 to $1.53 against a 30 PE. 17% ROE.

2010-12-09

PAST TOP PICK

39.390

Jeff Parent B. Eng. FCSI

(Top Pick Oct 7/09, Up 54%) He sold it. Still likes stock but it is showing a loss of momentum.

2010-10-08

BUY

42.110

Hap (Robert) Sneddon FCSI

Connects patient, doctor and insurance companies on the PD basis. Extremely high recurring revenue. Historically grown by acquisition but this year is more of a marking time year. Expects significant traction next year. In the top 10% of his data base.

2010-09-10

Comment

76.800

#1 on the Canadian healthcare weekly index and #3 on the monthly, which is good. This stock bumped up against $80.80 but that doesn't mean the story is over. If it came back to the trendline at around $70 or one above its $80 mark, it would be a good place to acquire.

2010-08-18

PAST TOP PICK

72.670

Mike S. Newton, CIM FCSI

(A Top Pick Aug 11/09. Up 69.16%.) Got stopped out but captured most of this 69%. Would love to get back into this one.

2010-07-12

DON'T BUY

75.550

Jason Donville

Good company but he can’t get over how expensive it is. Very good company.

2010-06-29

Comment

77.150

Paul Thornton

Continues to trade up near its highs and is trading in a very take range in the highs. This is a sign that the investors in it are not selling.

2010-06-25

TOP PICK

77.150

Paul Thornton

Pharmacy benefits company. Has had very strong growth and is a real favourite of US mutual and pension funds. Trading in a very tight range with highs around $77. Wouldn't be surprised to see a pullback to the $72 range because of market conditions, which would be a good place to get it.

2010-06-25

DON'T BUY

67.760

Jason Donville

Just get his head around how expensive it is. It doesn’t look close to cheap. LGI-T is preferred.

2010-03-23

PAST TOP PICK

65.740

(A Top Pick March 11/09. Up 161.34%.) Sold this in November or it

2010-03-18

PAST TOP PICK

50.670

Martin Hubbes, CFA

(Top Pick Mar 23/09, Up 90.34%) Took some profits.

2010-02-18

PAST TOP PICK

51.470

Mike S. Newton, CIM FCSI

(A Top Pick Aug 11/09. Up13.74%.) But stopped out but would still like to get it at the right price.

2010-02-02

PAST TOP PICK

56.150

(A Top Pick Jan 26/09. Up 171%.) Has done really well and continues to gain market share but slipped out of the top 25% of his database so he sold his holdings. 26X PE for 14% earnings growth is expensive.

2009-11-17

PAST TOP PICK

50.160

Martin Hubbes, CFA

(Top Pick Mar 23/09 Up 100.8%) Took some profits. Likes it long term, but it’s getting a little pricey

2009-10-21

TOP PICK

51.100

Jeff Parent B. Eng. FCSI

Beautiful chart pattern. No market correction shown. Significant move up in August and then a continuation of the trend. Looking for $60 sometime next summer. Will use $49 as a stop loss.

2009-10-07

TOP PICK

44.190

Mike S. Newton, CIM FCSI

Provider of pharmacy benefit management solutions, which reduces the costs of prescription drugs. Reported incredibly good earnings and has an incredibly good outlook.

2009-08-11

HOLD

29.890

Bill Carrigan

Has had a good run. Chart shows it is in a growth channel. Currently it looks like it's going to the top of the growth channel. Put your stop in at the lower channel.

2009-07-02

TOP PICK

26.400

Martin Hubbes, CFA

Basically do the software and provide services that allow pharmacy benefit companies to manage healthcare benefits. Everyone is trying to control costs and this company provides a solution.

2009-03-23

TOP PICK

25.170

Back office transaction between pharmacies, payer, insurance, etc. Recently reported very good earnings at about 100% year-over-year. Coming quarter earnings are expected to grow at about 84%. Continuing to gain market share. Analysts suggest being a strong buyer between $20-$22.

2009-03-11

BUY

18.980

Duncan Stewart

Provides technology solutions to the healthcare sector. Stock has hung in really well. Growing company that continues to win business, especially in the US. Great management and a great pipeline. Expect you could see another 10%-20% in this market.

2008-11-18

TOP PICK

15.280

Provides a backend solution for healthcare services companies. Large acquisition had some dilutive effects on earnings but will be back on track next year.

2008-06-24

TOP PICK

16.170

Back office solutions for Pharmacy/health benefit providers. Health card systems will change the shape of the company.

2008-05-30

TOP PICK

14.670

Provide the back-office systems for pharmacies. Made an interesting acquisition, which will add substantially to their overall business. Also announced a contract with Tennessee.

2008-04-29

TOP PICK

10.480

Provide the back end solution for a lot of pharmacies, and companies of that type. Are making acquisition of National Health in the states for $143 million, who is one of their major customers. Will add substantially to the size of the company. Last quarter was back on track, compared to the past.

2008-03-20

PAST TOP PICK

16.170

(A Top Pick Feb 1`3/07. Down 32%.) Provide back-office solutions for lot of healthcare providers. Really likes this one now. Has gone through some of the tough times. Still a Buy.

2008-01-15

PAST TOP PICK

14.510

(A Top Past Pick Dec14/06. Down 35.1%.) Still likes and is still buying.

2007-12-27

BUY

13.750

Alex Ruus

Pharmacy benefit management. Their solution is undercutting the big incumbents in the US. Really likes this story going forward. Likely bottoming and there should be good performance in 08.

2007-12-13

Comment

12.160

Fundamental problems drove the stock down. Has a good business model in pharmacy benefit management, which they can do for $2 per prescription that others need $5 for. Should give them a lot of traction. Missed Q2 earnings estimates and guided down for the year. Also made a mistake causing the state of Georgia to disallow them. They hope to get this back on track.

2007-11-23

PAST TOP PICK

12.200

Lesley Marks

(A Top Pick June 26/07. Down 60%.) Had just announced a possible $27 million contract at that time. They also missed on their quarter. Sold her holdings when they didn't get the contract.

2007-11-15

BUY

12.170

Provides back-office systems to pharmacies. Have sustainable revenues. A few issues this year in terms of earnings expectations. Built a staff a little bit beyond where they should have been. Had to pare back operations modestly. Trying to refocus into the higher growth area. Good price.

2007-11-14

BUY

15.820

Very visible cash flow and high margins. Gaining increased market share in the pharmacy management industry. Missed their numbers for the June quarter and lowered their guidance. Value managers are now buying. Revenues and expenses are in the US so a stronger Cdn$ does not affect them.

2007-09-28

PAST TOP PICK

18.590

(A Top Pick Sept 7/06. Up 14%.) Prescription processing between pharmacies, patients and insurance in the US. Still buying below $20US.

2007-09-07

BUY

30.850

Provides back-office for pharmacies. Located in Canada and US. Have been winning quite a few extensive contracts.

2007-07-12

TOP PICK

29.490

Lesley Marks

Healthcare information technology. Not a cyclical business. Good underlying growth. They can sell into their customer base to offer value added to decrease costs.

2007-06-26

TOP PICK

27.490

Back-office solution for pharmacies, both in the US and Canada. Doing a very good job of building out their product base. Extremely strong earnings/revenue growth.

2007-05-30

TOP PICK

26.480

(A Top Pick Sept 7/06. Up 60%.) Has had this in his portfolio for 5 years and expects it to be there another 5 years. A fantastic entry point on a 6 to 12 month basis.

2007-05-24

PAST TOP PICK

26.120

(A Top Pick May 16/06. Up 50.1%.) Back-office solution for pharmacies. Revenues are ticking along quite nicely. Still a Buy.

2007-05-11

TOP PICK

24.830

Provides back end solutions to pharmacies. Does a very good job of providing very efficient solutions. Revenues have been growing dramatically. Good margins and good growth.

2007-04-19

PAST TOP PICK

21.400

(A Top Pick Sept 7/06. Up 29.8%.) Has gone a little quiet. Had great 2007 guidance.

2007-03-26

DON'T BUY

22.880

Just announced a new $5 million contract. Ranks neutral in his model. Earnings were down 12%. High P/E of 29. Recently sold his holdings.

2007-02-28

TOP PICK

23.460

Provides software for the pharmacy business. Very strong balance sheet.

2007-02-13

HOLD

24.370

87 ranking in the model, which is quite high. Likes their recurring revenue. Bidding on a large number of medical contracts. Strong Hold.

2007-01-25

PAST TOP PICK

23.900

(A Top Pick Sept 7/06. Up 38.4%.) Still likes. Traction they are getting with their disruptive business model is changing the face of the pharmacy benefit industry in the US.

2007-01-24

TOP PICK

22.230

Provides software for the pharmacy sector. North American wide now. A lot of operations in the US as well as Canada. Very strong growth rate. Guidance is for $.72. Strong balance sheet and could make an acquisition which would add to earnings.

2007-01-19

TOP PICK

23.650

Provide pharmaceutical software for a growing need of companies that need these services. Has been growing quite dramatically.

2007-01-03

BUY

23.450

Provide software services for the payer market on the pharmaceutical side.. Has had a terrific move this year. Their growth is phenomenal. Looking for it to move higher.

2006-12-19

TOP PICK

22.470

(A Top Pick Sept 7/06. Up 32.9%.) Successfully introduced a business model into the pharmacy benefit management industry. Last 3 contracts have been real company transforming events. Cheap. A 3 to 5 year hold.

2006-12-14

DON'T BUY

21.220

In the top 25% of the database. Sold his holdings when he thought the stock was running out of gas. Bidding on some very substantial contracts, which is why the stock spiked up. Expensive.

2006-11-28

SELL

17.300

Things are slowing down with the company. Made a ton of sales and money on the conversion to Medicare part D. 70% of their income is from recurring revenue. Feels they will have a 30% tax increase. Sold his holdings.

2006-10-25

PAST TOP PICK

18.450

(A Top Pick Sept 29/05. Up 100.2%.) Sells software to pharmacies, etc. US legislation allowed additional Americans to get coverage under Medicaid. Growth rate is very strong.

2006-10-13

PAST TOP PICK

18.810

(A Top Pick Sept 29/05. Up 708.3%.) Still sees some pretty good earnings expectations.

2006-09-20

TOP PICK

16.690

Developments over the next year in a number of different areas in their business could be a potential double from here. Risk/reward is very good.

2006-09-07

PAST TOP PICK

15.680

(A Top Pick May 16/06. Down 10.2%.) Consolidated the stock and also did an issue and are looking to an acquisition in the US. Earnings outlook is still extremely strong.

2006-08-18

TOP PICK

14.800

In a very interesting position. Involved in the pharmacy business, streamlining operations with their software. Have announced a number of contracts over the last little while. Earnings will be quite strong.

2006-08-02

BUY

13.160

Ranks 51 in his model, which is in the top 10%. Earnings expected to go from $.50 to $.75. Have a huge amount of recurring revenue. A non-cyclical company.

2006-07-25

TOP PICK

12.990

Basically supplies software solutions for pharmacies. Growth rate has been very strong and is still in place. Looking for provincial contracts in Newfoundland and Quebec.

2006-07-14

BUY

14.360

Had a consolidation of 4 to 1. In the top 5% of his database. Expecting a 55% earnings growth. Some big opportunities coming over the next several months. Likes their recurring revenue.

2006-06-21

HOLD

4.060

Likes what they are doing from an execution point of view. Will be listed on NASDAQ and thinks the US investors will like the story.

2006-06-06

TOP PICK

4.350

Provide software services to pharmacies. Have been providing a nice return of late. Numbers are very strong and continue to look strong going forward. Very popular product, both in Canada and the US.

2006-05-16

BUY

4.030

Systems Excellence has good earnings. It has done well over the last year. It is a good opportunity. One of his top ten holdings. Ranks 16 in the database. It should survive even if we have a market pull back.

2006-03-13

TOP PICK

2.590

Howard Sutton

A defensive play in that 90% of their backlogs is recurring. They are in the software and service business, managing prescription benefit programs. Got into a new business about a year ago giving more into the pharmaceutical system. There is a US law on January 1 that will be a boon to this company.

2005-12-22

TOP PICK

2.290

The company is interesting. They provide software to pharmacies to streamline their operations. The company has jusy got a big contract. Earnings will be $0.09 this year and $0.13 next year.

2005-09-29

BUY on WEAKNESS

2.200

Ranks highly his database. Earnings are expected to go from $0.11 to $0.15, a 21% earnings growth. Against a 15 P/E gives you a .8 P/E to growth. If the market pulls back you may be able to buy it below $2.

2005-09-15

DON'T BUY

2.300

Jean-Francois Tardif

Has disappointed him in the past and seems to do this all the time. Recent results don't look very good to him. Made a lot of acquisitions, but earnings are not that good.

2005-08-29

PAST TOP PICK

1.550

(A Top Pick Nov 19/03. Down 37%.) Sold off some time ago. Company is fairly sound and has cash.

2005-05-31

TOP PICK

1.480

Werner Muehelemann

Technology stock valuations have come down a lot and is a sector that still has potential to grow. Trades around 11 X forward earnings which is pretty cheap. They are going to double their earnings from last year's. Likes the health care sector that they are in. Revenue model is going more to a transactional basis rather than license.

2005-03-23

DON'T BUY

1.350

Ranks borderline of the bottom 1/3 of the database. Earnings estimates have been revised downward. 12 PE overall for reasonable are ROE of 21%.

2004-08-20

BUY

1.120

John Embry

Likes management. As an interesting land package in Chile. Speculative.

2004-04-15

WAIT

1.870

Expect the stock won't do a lot until they do a major acquisition along with a finance. Well-run.

2004-04-08

BUY

1.850

Ed Ho

Dropped because of speculation in the market that they were going to do an acquisition. Likes management. Have good revenue and are growing reasonably.

2004-03-24

WAIT

2.450

About mid-point in the database. The large contract they have, runs out of steam the middle of this year.

2004-01-30

DON'T BUY

2.250

Andrew McCreath

Not a big fan of medical tech system companies. Stocks had big run. Wouldn't buy at this level.

2004-01-28

DON'T BUY

2.200

Andrew McCreath

Not a big fan of medical technology information systems as so many have had good stories, but never made any money.

2004-01-26

BUY on WEAKNESS

2.240

Likes the company. Have had some pretty good traction. Likes the space. Would buy under $2.

2004-01-23

BUY

2.500

Ranks very well in the database. Year-over-year earnings growth is up 40%. ROE is expected to be 41%.

2004-01-05

TOP PICK

2.230

Earnings growth is consistent 65% of earnings is recurring which is very high. Very cheap on a multiples basis.

2003-12-17

BUY

2.370

A bit of an overhang in that there is a lot of stock for sale. Starting to get traction with their customers. Might go to $3.50/4 long-term. An acquisition target.

2003-12-04

BUY

2.440

Has done very well and thinks there is still opportunity. In the top 8% of the database. Earnings are expected to grow from 13¢ to 17¢. Continuing to work on some very large contracts and hopefully they will be closed in the new year.

2003-11-21

TOP PICK

2.480

Has delivered 2 very profitable quarters, 3¢ a share and are looking for them to earn 12¢ 13¢ for the Feb year-end and .20¢ next year. Probably will be a takeover.

2003-11-19

WAIT

2.000

There is some profit taking going on. There is a big overhang in that some dealers are try to get rid of a block which is putting short-term pressure on the stock. Still a good story. This space is pretty strong. Expected to be acquired ultimately.

2003-11-14

BUY

2.340

Ranks high in the model. Earnings are forecast to grow from 0.14¢ 0.17¢. A 15% earnings growth against a 15 P/E, gives a good P. E. growth. Year-over-year sales growth is pretty good.

2003-11-07

BUY

2.460

Glenn Paradis, BA, CFA

Likes the business. They understand the dynamics of the industry. A lot of opportunity for them to continue to grow top and bottom. Good price. A little bit risky.

2003-10-24

DON'T BUY

2.310

Andrew McCreath

A pretty tough industry to consistently make money in. Has delivered, but feels the shares are a little pricey.

2003-10-20

BUY

2.860

Ranks as #6 in the Canadian database on techs. Still thinks there is good opportunity going forward. Earnings are expected to grow from $0.08 to $.13 per share. They are bidding on some very interesting contracts.

2003-10-10

DON'T BUY

2.510

Would prefer at a lower price.

2003-09-22

BUY

2.590

New management has turned the company around. Starting to get an accelerating contract win situation. (Do back office transaction between pharmacies, payer, insurance company, etc. Good product.) Winning market share.

2003-09-09

BUY

2.650

60% of their revenue is recurring. Strong transaction based. Still pretty good opportunities. Should be more upside.

2003-08-29

TOP PICK

2.520

Kyle McKay

Estimating that they will do about $15 million in revenues and $16/18 per share. Good price.

2003-08-28

STRONG BUY

2.200

Software company that facilitates connection between the pharmacy and insurance company.Earnings should go up.No debt.Trading below 10 times earnings.A great story.

2003-08-26

BUY

1.100

Has just broken out from a technical analysis. Working on some long term contracts. Should move forward.

2003-05-16

WEAK BUY

0.780